Neo Ivy Capital Management - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$496,000
+740.7%
18,496
+1332.7%
0.57%
+848.3%
Q2 2021$59,000
-52.4%
1,291
-56.5%
0.06%
-55.9%
Q1 2021$124,000
-63.5%
2,966
-62.7%
0.14%
-64.1%
Q4 2020$340,000
+45.9%
7,952
-10.6%
0.38%
+60.6%
Q3 2020$233,000
-88.0%
8,895
-91.3%
0.24%
-67.8%
Q2 2020$1,939,000
+6586.2%
102,462
+6336.1%
0.73%
+1459.6%
Q1 2020$29,000
-92.4%
1,592
-93.1%
0.05%
-81.1%
Q3 2019$381,000
-73.6%
23,093
-72.5%
0.25%
-69.4%
Q2 2019$1,443,00083,9660.81%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders